Japan’s Ministry Considers Interim Measures for OTC Online Purchase Ban
This article was originally published in PharmAsia News
Executive Summary
Japan's Ministry of Health, Labor and Welfare decided May 11 on a two year grace period for online purchases of over-the-counter drugs. The policy only applies to people who are living on remote islands and those who are currently using specific drugs on a regular basis. In February, MHLW ordered a ban on online purchases of most OTC drugs that belong to class 1 and class 2, and only drugs that are in the lower-risk class 3 are allowed to be sold online. The new policy is to take effect June 1. The interim measure only applies to class 2 drugs. (Click here for more - Japanese language
You may also be interested in...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.